Pandemic and Seasonal Influenza Vaccine Preparedness and Response: Harnessing Lessons from the Efforts to Mitigate the COVID-19 Pandemic
The National Academy of Medicine has established an International Committee (IC) in coordination with the U.S. Health and Human Services Office of Global Affairs (OGA) to inform and facilitate its efforts to advance global influenza pandemic preparedness. The IC will provide OGA an iterative, interactive, multi-disciplinary, expert-informed process for assessing the global impact that capabilities, technologies, processes, and policies developed in response to COVID-19 could have on pandemic and seasonal influenza global preparedness and response, especially involving vaccine development.
In progress
Any project, supported or not by a committee, that is currently being worked on or is considered active, and will have an end date.
Description
The NAM will convene an International Committee of domestic and international experts from across sectors (e.g., government, academia, industry, civil society, international public health organizations) and a variety of disciplines to provide an iterative, interactive, multi-disciplinary, expert-informed process for assessing the global impact that capabilities, technologies, processes, and policies developed for COVID-19 could have on pandemic and seasonal influenza global preparedness and response, especially regarding vaccine development. The International Committee will provide recommendations developed by four concurrent National Academies ad hoc committees. The recommendations of these ad hoc committees will be released as four peer-reviewed reports on how to improve the global design, composition, clinical trials, production, scale-up, regulatory approval, distribution of influenza vaccines, and post-approval surveillance for adverse events.
The four concurrent ad hoc committees will examine the emerging evidence on research and development for COVID-19 relevant to advancing seasonal and pandemic influenza global preparedness and response. The focus areas of the four consensus studies will be:
- Concurrent Consensus Study 1: Vaccine research and development, including platforms in discovery and manufacturing
- Concurrent Consensus Study 2: Distribution and supply chain;
- Concurrent Consensus Study 3: Public health interventions and countermeasures (NPIs, Diagnostics, and Treatment Strategies)
- Concurrent Consensus Study 4: International coordination, innovative partnerships, and sustainable financing for Influenza preparedness and response
Collaborators
Sponsors
Department of Health and Human Services
Major units and sub-units
Center for Health, People, and Places
Collaborator
National Academy of Medicine
Lead
National Academy of Medicine President's Office
Lead
Biomedical and Health Sciences Program Area
Collaborator